Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hidden toll: cystic fibrosis teens face depression risk

NCT ID NCT03424486

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how common depression and anxiety are in teenagers with cystic fibrosis and their parents. Researchers used questionnaires during routine clinic visits to screen for symptoms. The goal was to better understand mental health needs in this group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help clinics better identify and support mental health needs in cystic fibrosis patients and families.
What could go wrong
This is an observational study with only 108 participants, so results may not apply to all cystic fibrosis patients. It does not test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

108 people

The number who actually took part.

Started

Nov 2017

Finished

Jul 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1. Patients with CF aged 14 to 17. Patients awaiting organ transplantation will be included in the study, but those who have received an organ transplant shall be excluded. No other exclusionary criteria will be used. 2. Parents of the patients included.

Ages

14 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with CF * 14 to 17 year old * Parents of a included patient Exclusion Criteria: \- Patient who have received an organ transplant shall be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cystic fibrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder cystic fibrosis Depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cystic fibrosis

Contacts and locations

Locations

  • CRCM - Service de Pneumologie Pédiatrique - CHU Amiens - Site Sud

    Amiens, 80000, France

  • CRCM - Service de Pédiatrie - Pôle FEH - CHU Caen)

    Caen, 14000, France

  • CRCM - Service de Pédiatrie A - American Memorial Hospital

    Reims, 51100, France

  • CRCM / Service de Médecine Infantile - Hôpital d'Enfants - CHRU Nancy

    Nancy, 54511, France

  • CRCM / Service de Pédiatrie _ Hôpital de Clocheville - CHRU de Tours

    Tours, 37000, France

  • CRCM Enfants - Service de Pneumologie - Hôpital Jean Minjoz

    Besançon, 25000, France

  • CRCM Pédiatrique - Hôpital des Enfants

    Bordeaux, 33000, France

  • Department of Pneumology - CRCM- Necker - Enfants malades Hospital (AP-HP) -

    Paris, Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.